RAPT THERAPEUTICS

RAPT Therapeutics is a clinical stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. Utilizing its proprietary discovery and development engine, the company is developing highly selective small molecules designed to modulate the critical immune responses underlying these diseases. In its first four years since inception, RAPT has discov... ered and advanced two unique drug candidates, each targeting C-C motif chemokine receptor 4. The company’s lead oncology drug candidate, FLX475, reached the clinic in just two and a half years with its lead inflammation drug candidate, RPT193, also in the clinic. The company is also pursuing a range of targets, including general control nonderepressible 2 and hematopoietic progenitor kinase 1, that are in the discovery stage of development.

#SimilarOrganizations #People #Financial #Website #More

RAPT THERAPEUTICS

Social Links:

Industry:

Biotechnology Health Care Medical Pharmaceutical Therapeutics

Founded:

2015-03-04

Address:

South San Francisco, California, United States

Country:

United States

Website Url:

http://www.rapt.com

Total Employee:

101+

Status:

Active

Contact:

+116504899000

Email Addresses:

[email protected]

Total Funding:

369.7 M USD

Technology used in webpage:

SPF SSL By Default Microsoft Exchange Online Office 365 Mail IPv6 Microsoft Azure DNS GoDaddy DNS Microsoft GoDaddy SSL Smart App Banner

Similar Organizations

actym-therapeutics-inc-logo

Actym Therapeutics, Inc.

Actym Therapeutics is a privately-held biotech focused on the discovery and development of novel immuno-oncology therapies to treat cancer.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

aprea-logo

Aprea

Aprea focuses on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53.

blueprint-medicines-logo

Blueprint Medicines

Blueprint Medicines engages in the discovery and development of highly selective kinase inhibitors for genomically defined cancer subsets.

cyclica-logo

Cyclica

Cyclica is the partner of choice for data-driven drug discovery.

effector-therapeutics-logo

Effector Therapeutics

Effector Therapeutics is an early-stage company focused on the discovery and development of small molecule cancer therapeutics.

elicio-therapeutics-logo

Elicio Therapeutics

Elicio Therapeutics develops an immuno-tumor vaccine to treat cancer.

gigagen-logo

GigaGen

GigaGen specialized in the early discovery and development of recombinant biotherapeutic medicines.

glycobiochem-logo

GlycoBioChem

GlycoBioChem is focused on discovery and development of novel small-molecules for the purposes of research and treatment of human diseases.

insitro-logo

Insitro

Insitro is a drug discovery and development startup that utilizes machine learning and biology to transform drug discovery.

jounce-therapeutics-logo

Jounce Therapeutics

Jounce Therapeutics is developing cancer immune-therapies to harness the immune system to attack cancerous cells and tumors.

lucy-therapeutics-logo

Lucy Therapeutics

Lucy Therapeutics is a biotech company providing effective treatments for neurological diseases start with the mitochondria.

mindera-corporation-logo

MiNDERA Corporation

MiNDERA Dx conducts research and development on non-invasive molecular testing for skin cancer and other skin diseases.

pliant-therapeutics-logo

Pliant Therapeutics

Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.

not_available_image

QureBio

QureBio focuses on the research and development of innovative macromolecular biopharmaceuticals.

rgenta-therapeutics-logo

Rgenta Therapeutics

Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology.

shouti-logo

ShouTi

ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR.

versameb-logo

Versameb

Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.

westlake-therapeutics-logo

Westlake Therapeutics

The company is committed to the development of a variety of innovative cell therapy products for rare diseases, cancer, etc.

xoma-logo

XOMA

XOMA is at the forefront of antibody discovery and development, one of the most powerful and transformative fields of drug innovation

zavante-therapeutics-logo

Zavante Therapeutics

Zavante focuses on developing novel therapies to improve the outcomes of hospitalized patients.

Current Advisors List

beth-seidenberg_image

Beth Seidenberg Member of the Board of Directors @ Rapt Therapeutics
Board_member
2015-04-01

david-goeddel_image

David Goeddel Member of the Board of Directors @ Rapt Therapeutics
Board_member
2015-04-01

linda-kozick_image

Linda Kozick Board Member @ Rapt Therapeutics
Board_member
2016-12-01

william-j-rieflin_image

William J. Rieflin Board Member @ Rapt Therapeutics
Board_member
2015-04-01

michael-giordano_image

Michael Giordano Member of the Board Of Directors @ Rapt Therapeutics
Board_member

Current Employees Featured

brian-wong_image

Brian Wong
Brian Wong Founder & CEO @ Rapt Therapeutics
Founder & CEO
2015-08-01

william-ho_image

William Ho
William Ho Chief Medical Officer @ Rapt Therapeutics
Chief Medical Officer
2015-05-01

dave-wustrow_image

Dave Wustrow
Dave Wustrow VP Discovery and Preclinical Development @ Rapt Therapeutics
VP Discovery and Preclinical Development

paul-kassner_image

Paul Kassner
Paul Kassner Vice President of Quantitative and Computational Biology @ Rapt Therapeutics
Vice President of Quantitative and Computational Biology

kristina-green_image